PBS dispute could leave MS patients with huge bills for crucial drugs Ocrevus and Kesimpta
A dispute over how Australia prices medicines has sparked fears 10,000 people with multiple sclerosis will be forced…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRO: Fenebrutinib matched ocrelizumab in slowing PPMS progression,…
Weight loss drugs are rewriting the global business of how we eat
A US pharmaceutical company went to a $1.5 trillion valuation last week, joining a club that up until…
Shanghai to scrap all foreign investment limits on manufacturing facilities
Mainland China’s commercial and financial hub Shanghai has pledged to remove all regulatory hurdles for foreign investors to…
Some bright spots emerge in corporate earnings despite tariffs
Some of the world’s top tech firms, including U.S. tech giant Alphabet, South Korean chipmaker SK Hynix and…